Clinical Trial Update: Levosimendan in High Risk Patients Undergoing Cardiac Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating levosimendan in high-risk patients undergoing cardiac surgery for Low Cardiac Output Syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Cardiac Output Syndrome

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Università Vita-Salute San Raffaele | Conditions: Low Cardiac Output Syndrome | Phase 4 | Status: COMPLETED